Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
Der Urologe. Ausg. A|September 20, 2014
[Pharmaceutical treatment of advanced urinary bladder cancer: new developments in 2014]S C Schmid, J E Gschwend, M RetzDer Urologe. Ausg. A|January 16, 2016
[Update 2016 - Immunotherapy for urothelial carcinoma]M Retz, J E Gschwend, S C SchmidAktuelle Urologie|February 7, 2014
[Current developments in the medical treatment of advanced urothelial carcinoma of the bladder]S C Schmid, J E Gschwend, M Retz, et al.Urologie (Heidelberg, Germany)|November 9, 2022
["Surgery only" is not enough: potential of multimodal therapy in urothelial bladder carcinoma]S C Schmid, J Lewerich, M Retz, et al.Urologie (Heidelberg, Germany)|November 30, 2022
[Value of immunotherapy in the perioperative treatment of localized muscle invasive bladder cancer]J Lewerich, S C Schmid, J E Gschwend, et al.Organic & Biomolecular Chemistry|August 20, 2014
1,3-Halogen migration as an entry to aryl coppers from an unintuitive starting materialR J Van Hoveln, S C Schmid, J M SchomakerDer Urologe. Ausg. A|May 31, 2020
[Immuno-oncological approaches in the perioperative therapy of muscle invasive bladder cancer]S C Schmid, F J Koll, F Beckert, et al.Der Urologe. Ausg. A|October 15, 2013
[Systemic therapy of metastatic bladder cancer.]M Retz, S C Schmid, M W Kramer, et al.Der Urologe. Ausg. A|March 12, 2014
[Hands-on teaching for students in urology: the use of peer teaching and simulators]S C Schmid, P O Berberat, J E Gschwend, et al.Chemical Science|July 14, 2015
Formal Asymmetric Hydrobromination of Styrenes via Copper-Catalyzed 1,3-Halogen MigrationR J Van Hoveln, S C Schmid, M Tretbar, et al.Pageof 2